Martin Salzmann

1.9k total citations
19 papers, 217 citations indexed

About

Martin Salzmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Martin Salzmann has authored 19 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Martin Salzmann's work include Cancer Immunotherapy and Biomarkers (7 papers), Brain Metastases and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Martin Salzmann is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Brain Metastases and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Martin Salzmann collaborates with scholars based in Germany and France. Martin Salzmann's co-authors include Jessica C. Hassel, Alexander Enk, Y Bascoulergue, Jacques Guyotat, Philippe Bret, Frederik Marmé, Carmen Loquai, Selma Ugurel, Kai‐Martin Thoms and Imad Maatouk and has published in prestigious journals such as Journal of Clinical Oncology, Neurosurgery and European Journal of Cancer.

In The Last Decade

Martin Salzmann

19 papers receiving 211 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Salzmann Germany 8 113 61 41 35 35 19 217
Noah Graham United States 9 205 1.8× 137 2.2× 100 2.4× 27 0.8× 17 0.5× 26 290
Natalia Castrejón de Anta Spain 7 113 1.0× 23 0.4× 26 0.6× 18 0.5× 24 0.7× 20 206
ZoAnn E. Dreyer United States 7 57 0.5× 47 0.8× 25 0.6× 50 1.4× 6 0.2× 8 276
Lourdes Martín‐Martín Spain 6 106 0.9× 71 1.2× 58 1.4× 9 0.3× 45 1.3× 6 238
Nadia Bianco Italy 7 123 1.1× 74 1.2× 46 1.1× 20 0.6× 3 0.1× 17 171
Lavinia Grapulin Italy 8 70 0.6× 17 0.3× 37 0.9× 8 0.2× 21 0.6× 17 147
Anke Krause Germany 8 105 0.9× 19 0.3× 22 0.5× 130 3.7× 55 1.6× 10 308
Lara Malerba Italy 11 151 1.3× 17 0.3× 38 0.9× 63 1.8× 21 0.6× 18 261
Tsutomu Chihara Japan 9 56 0.5× 74 1.2× 44 1.1× 25 0.7× 16 0.5× 12 204
Marcelo Luiz Balancin Brazil 9 46 0.4× 36 0.6× 6 0.1× 30 0.9× 11 0.3× 20 136

Countries citing papers authored by Martin Salzmann

Since Specialization
Citations

This map shows the geographic impact of Martin Salzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Salzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Salzmann more than expected).

Fields of papers citing papers by Martin Salzmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Salzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Salzmann. The network helps show where Martin Salzmann may publish in the future.

Co-authorship network of co-authors of Martin Salzmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Salzmann. A scholar is included among the top collaborators of Martin Salzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Salzmann. Martin Salzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salzmann, Martin, Alexander Wald, Henner Stege, et al.. (2023). Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study. Cancers. 15(5). 1426–1426. 1 indexed citations
2.
Salzmann, Martin, Alexander Enk, & Jessica C. Hassel. (2023). S100 as Serum Tumor Marker in Advanced Uveal Melanoma. SSRN Electronic Journal. 2 indexed citations
3.
Salzmann, Martin, Alexander Enk, & Jessica C. Hassel. (2023). S100 as Serum Tumor Marker in Advanced Uveal Melanoma. Biomolecules. 13(3). 529–529. 7 indexed citations
4.
Salzmann, Martin, Carmen Loquai, David Rafei‐Shamsabadi, et al.. (2022). MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study. European Journal of Cancer. 166. 24–32. 11 indexed citations
5.
Wald, Alexander, et al.. (2022). Cytokine alterations during paraneoplastic neutrophilia and leukemoid reaction in patients with advanced melanoma. Cancer Immunology Immunotherapy. 72(2). 509–513. 1 indexed citations
6.
Salzmann, Martin, Klaus Hess, Kristin Lang, et al.. (2022). Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy. Strahlentherapie und Onkologie. 198(10). 884–891. 3 indexed citations
7.
Hassel, Jessica C., Martin Salzmann, Christian Menzer, et al.. (2022). Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA). OncoImmunology. 11(1). 2066609–2066609. 19 indexed citations
8.
9.
Salzmann, Martin, Georgi Tosev, Dirk Schadendorf, et al.. (2021). Male fertility during and after immune checkpoint inhibitor therapy: A cross-sectional pilot study. European Journal of Cancer. 152. 41–48. 35 indexed citations
10.
Salzmann, Martin, et al.. (2021). Durable Complete Remission of Leptomeningeal Melanoma by Intrathecal Methotrexate Maintained with Systemic Ipilimumab. Immunotherapy. 13(13). 1079–1083. 2 indexed citations
11.
Salzmann, Martin, Adriana Rendón, Ferdinand Toberer, & Jessica C. Hassel. (2021). Generalisiertes perforierendes Granuloma anulare: ein Fallbericht. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 19(4). 585–587. 1 indexed citations
12.
Salzmann, Martin, Karolina Benesova, Kristina Buder‐Bakhaya, et al.. (2020). Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients. Cancers. 12(10). 3004–3004. 3 indexed citations
13.
Steeb, Theresa, Anja Wessely, Konstantin Drexler, et al.. (2020). The Quality of Practice Guidelines for Melanoma: A Methodologic Appraisal with the AGREE II and AGREE-REX Instruments. Cancers. 12(6). 1613–1613. 15 indexed citations
14.
Salzmann, Martin, Ulrike Leiter, Carmen Loquai, et al.. (2020). Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study. European Journal of Cancer. 138. 125–132. 47 indexed citations
15.
Salzmann, Martin, Frederik Marmé, & Jessica C. Hassel. (2019). Prophylaxis and Management of Skin Toxicities. Breast Care. 14(2). 72–77. 22 indexed citations
16.
Hassel, Jessica C., Martin Salzmann, Matthias F. Haefner, et al.. (2019). Evaluation of radiotherapeutic and immune-modulatory response to whole brain radiotherapy or stereotactic radiosurgery in patients with brain metastases from malignant melanoma treated with or without ipilimumab (ELEKTRA).. Journal of Clinical Oncology. 37(15_suppl). e14104–e14104. 2 indexed citations
17.
Bret, Philippe, Martin Salzmann, Y Bascoulergue, & Jacques Guyotat. (1994). Dural Arteriovenous Fistula of the Posterior Fossa Draining into the Spinal Medullary Veins???An Unusual Cause of Myelopathy. Neurosurgery. 35(5). 965???969–965???969. 5 indexed citations
18.
Bret, Philippe, Martin Salzmann, Y Bascoulergue, & Jacques Guyotat. (1994). Dural Arteriovenous Fistula of the Posterior Fossa Draining into the Spinal Medullary Veins–An Unusual Cause of Myelopathy. Neurosurgery. 35(5). 965–969. 31 indexed citations
19.
Vighetto, Alain, et al.. (1991). Korsakoff's syndrome as the initial presentation of multiple sclerosis. Journal of Neurology. 238(6). 351–354. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noah Graham Breakdown of academic impact, for papers by Natalia Castrejón de Anta Breakdown of academic impact, for papers by ZoAnn E. Dreyer Breakdown of academic impact, for papers by Lourdes Martín‐Martín Breakdown of academic impact, for papers by Nadia Bianco Breakdown of academic impact, for papers by Lavinia Grapulin Breakdown of academic impact, for papers by Anke Krause Breakdown of academic impact, for papers by Lara Malerba Breakdown of academic impact, for papers by Tsutomu Chihara Breakdown of academic impact, for papers by Marcelo Luiz Balancin
Rankless by CCL
2026